Literature DB >> 10413589

p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.

K Nakamura1, T Shirai, S Morishita, S Uchida, K Saeki-Miura, F Makishima.   

Abstract

Recent studies of intracellular signal transduction mechanisms for the transforming growth factor-beta (TGF-beta) superfamily have focused on Smad proteins, but have paid little attention to mitogen-activated protein (MAP) kinase cascades. Here we demonstrate that growth/differentiation factor-5 (GDF-5), but neither bone morphogenetic protein-2 (BMP-2) nor TGF-beta1, fully promotes the early phase of the chondrogenic response by inducing cellular condensation followed by cartilage nodule formation in a mouse chondrogenic cell line, ATDC5. We investigated which, if any, of the three major types of MAP kinase plays a functional role in the promotion of chondrogenesis induced by GDF-5. GDF-5 induced phosphorylation of p38 MAP kinase and extracellular signal-regulated kinase (ERK) but not that of c-Jun N-terminal kinase (JNK). The phosphorylation of p38 MAP kinase was also induced by BMP-2 and TGF-beta1. An inhibitor of p38 and p38 beta MAP kinase, SB202190, showed complete inhibition of cartilage nodule formation but failed to affect alkaline phosphatase (ALP) activity induced by GDF-5. Expression of the type II collagen gene, a hallmark of chondrogenesis in vertebrates, was also induced by GDF-5 treatment and strongly suppressed by SB202190. On the other hand, although an inhibitor of MAP/ERK kinase, PD98059, inhibited the rapid phosphorylation of ERK by GDF-5, it inhibited neither ALP activity nor cartilage nodule formation induced by GDF-5. These results strongly suggest that the p38 MAP kinase cascade is involved in GDF-5 signaling pathways and that a role of the p38 MAP kinase pathway is necessary over a longer period to promote chondrogenesis in ATDC5 cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413589     DOI: 10.1006/excr.1999.4535

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  58 in total

1.  Sequential actions of BMP receptors control neural precursor cell production and fate.

Authors:  D M Panchision; J M Pickel; L Studer; S H Lee; P A Turner; T G Hazel; R D McKay
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

2.  Delineation of in vitro chondrogenesis of human synovial stem cells following preconditioning using decellularized matrix.

Authors:  Ying Zhang; Jingting Li; Mary E Davis; Ming Pei
Journal:  Acta Biomater       Date:  2015-04-08       Impact factor: 8.947

3.  Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the Akt kinase-dependent pathway.

Authors:  Li Chen; Diyako Qanie; Abbas Jafari; Hanna Taipaleenmaki; Charlotte H Jensen; Anna-Marja Säämänen; Maria Luisa Nueda Sanz; Jorge Laborda; Basem M Abdallah; Moustapha Kassem
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

4.  Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6.

Authors:  Jaroslav Truksa; Hongfan Peng; Pauline Lee; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

5.  p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation.

Authors:  Lee-Anne Stanton; Shalev Sabari; Arthur V Sampaio; T Michael Underhill; Frank Beier
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

6.  ERK activation is required for hydrostatic pressure-induced tensile changes in engineered articular cartilage.

Authors:  G D DuRaine; K A Athanasiou
Journal:  J Tissue Eng Regen Med       Date:  2012-12-18       Impact factor: 3.963

7.  WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair.

Authors:  Dorothy M French; Raji J Kaul; Aloma L D'Souza; Craig W Crowley; Min Bao; Gretchen D Frantz; Ellen H Filvaroff; Luc Desnoyers
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.

Authors:  Kai Heinecke; Axel Seher; Werner Schmitz; Thomas D Mueller; Walter Sebald; Joachim Nickel
Journal:  BMC Biol       Date:  2009-09-07       Impact factor: 7.431

9.  Inhibition of TAK1 and/or JAK can rescue impaired chondrogenic differentiation of human mesenchymal stem cells in osteoarthritis-like conditions.

Authors:  Henk M van Beuningen; Marloes L de Vries-van Melle; Elly L Vitters; Wim Schreurs; Wim B van den Berg; Gerjo J V M van Osch; Peter M van der Kraan
Journal:  Tissue Eng Part A       Date:  2014-03-25       Impact factor: 3.845

10.  Smad3 activates the Sox9-dependent transcription on chromatin.

Authors:  Takayuki Furumatsu; Toshifumi Ozaki; Hiroshi Asahara
Journal:  Int J Biochem Cell Biol       Date:  2008-11-08       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.